HomeInsightsEPS

Sandu Pharmaceuticals Ltd EPS

Sandu Pharmaceuticals Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.1 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

EPS

₹ 1.51

Last updated on: Nov 22, 2024

Key Highlights

  • The Earning per Share of Sandu Pharmaceuticals Ltd is ₹ 1.51 as of 22 Nov 24 .
  • The earning per share of Sandu Pharmaceuticals Ltd changed from ₹ 0.19 to ₹ 1.95 over 10 quarters. This represents a CAGR of 153.81% .

Historical Earning per Share of Sandu Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Sandu Pharmaceuticals Ltd

Market Cap

54 Cr

EPS

1.5

P/E Ratio (TTM) *

37.6

P/B Ratio (TTM) *

1.3

Day’s High *

57.64

Day’s Low

56.0

DTE *

0.0

ROE *

3.6

52 Week High

85.0

52 Week Low

54.0

ROCE *

5.3

Market Price of Sandu Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Sandu Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202456.79
21 Nov 202457.4
19 Nov 202457.52
18 Nov 202457.35
14 Nov 202457.97
13 Nov 202457.64
12 Nov 202458.01
11 Nov 202459.77
08 Nov 202456.2
07 Nov 202457.85

BlinkX Score for Sandu Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sandu Pharmaceuticals Ltd

Market Value

55

Asset Value

22

1.5 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Historical Market Cap of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sandu Pharmaceuticals Ltd News Hub

News

Sandu Pharmaceuticals declare Quarterly Result

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 N...

Read more

05 Nov 202413:43

News

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

13 Aug 202409:53

News

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company ...

Read more

13 Aug 202409:53

News

Sandu Pharmaceuticals schedules board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 A...

Read more

06 Aug 202414:29

News

Sandu Pharmaceuticals to discuss results

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 Ju...

Read more

01 Jun 202409:25

News

Sandu Pharmaceuticals to hold board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 M...

Read more

22 May 202412:40

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Sandu Pharmaceuticals Ltd

What is the EPS of Sandu Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Sandu Pharmaceuticals Ltd is 1.51. An EPS is the amount of net income attributed to each share of a common stock.

How is Sandu Pharmaceuticals Ltd EPS calculated?

The EPS of Sandu Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sandu Pharmaceuticals Ltd report its EPS?

Sandu Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sandu Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Sandu Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sandu Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Sandu Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*